Evidence map›Paper›PMID 35488049›Full record

ArticleMolecular genetics and genomics : MGG2022

Combining cytogenetic and genomic technologies for deciphering challenging complex chromosomal rearrangements.

Rachel Michaelson-Cohen, Omer Murik, Sharon Zeligson, Orit Lobel, Omri Weiss, Elie Picard, Tzvia Mann, Hagar Mor-Shaked, David A Zeevi, Reeval Segel

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rachel Michaelson-CohenMedical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel. rachelmc@szmc.org.il.ORCID http://orcid.org/0000-0002-2543-664X
Omer MurikTranslational Genomics Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Sharon ZeligsonCytogenomics Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Orit LobelCytogenomics Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Omri WeissMedical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Elie PicardFaculty of Medicine, Hebrew University, Jerusalem, Israel.
Tzvia MannTranslational Genomics Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Hagar Mor-ShakedFaculty of Medicine, Hebrew University, Jerusalem, Israel.
David A ZeeviTranslational Genomics Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Reeval SegelMedical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Shaare Zedek Medical Center · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex chromosomal rearrangements (CCRs), a class of structural variants (SVs) involving more than two chromosome breaks, were classically thought to be extremely rare. As advanced technologies become more available, it has become apparent that CCRs are more common than formerly thought, and are a substantial cause of genetic disorders. We attempted a novel approach for solving the mechanism of challenging CCRs, which involve repetitive sequences, by precisely identifying sequence-level changes and their order. Chromosomal microarray (CMA) and FISH analyses were used for interpretation of SVs detected by whole exome sequencing (WES). Breakpoint junctions were analyzed by Nanopore sequencing, a novel long-read whole genome sequencing tool. A large deletion identified by WES, encompassing the FOXF1 enhancer, was the cause of alveolar capillary dysplasia and respiratory insufficiency, resulting in perinatal death. CMA analysis of the newborn's mother revealed two duplications encompassing the deleted region in the proband, raising our hypothesis that the deletion resulted from the mother's CCR. Breakpoint junctions of complex SVs were determined at the nucleotide level using Nanopore long-read sequencing. According to sequencing results of breakpoint junctions, the CCR in the newborn was considered the consequence of at least one double-strand break during meiosis, and reassembly of DNA fragments by intra-chromosomal homologous recombination. Our comprehensive approach, combining cytogenetics and long-read sequencing, enabled delineation of the exact breakpoints in a challenging CCR, and proposal of a mechanism in which it arises. We suggest applying our integrative approach combining technologies for deciphering future challenging CCRs, enabling risk assessment in families.

Indexed as

Chromosome AberrationsGenomeChromosomesCytogenetic AnalysisFemaleGenomicsHumansPregnancyAdvanced genomic technologiesChromosomal microarray (CMA)Complex chromosomal rearrangements (CCRs)Nanopore long-read sequencingWhole exome sequencing (WES)Whole genome sequencing (WGS)

Identifiers

PMID35488049
OpenAlexW4225132577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.